AZUR-2, a phase III, open-label, randomized study of perioperative dostarlimab monotherapy vs standard of care in previously untreated patients with T4N0 or stage III dMMR/MSI-H resectable colon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback